Thema
610
112
Study Type: Interventional
100
Recruitment Status: Not yet recruiting
40
Recruitment Status: Recruiting
28
Phase: Phase 3
22
Recruitment Status: Authorised-recruitment may be ongoing or finished
22
Phase: Phase 4
20
Medical Condition: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
18
Recruitment Status: Completed
18
Phase: Phase 2/Phase 3
12
Study Type: Observational
12
Phase: Phase 2
10
Medical Condition: COVID-19 disease. COVID-19;U07.2, U07
4
Medical Condition: COVID-19 pneumonia. COVID-19, virus identified;U07.1
4
Medical Condition: COVID-19. COVID-19, virus identified;U07.1
4
Medical Condition: COVID-19;Therapeutic area: Diseases [C] - Virus Diseases [C02]
4
Recruitment Status: Complete: follow-up complete
4
Medical Condition: ;B44.0 - Invasive pulmonary aspergillosis
2
Medical Condition: Acute Respiratory Distress Syndrome (ARDS) caused by SARS-Cov-2 infection;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Acute respiratory distress syndrome (ARDS) in patients affected by COVID-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Adult patients with COVID-19 and severe hypoxia. MedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862 MedDRA version: 21.1Level: PTClassification code 10021143Term: HypoxiaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Adult patients with SARS-CoV-2 infection (COVID19) requiring hospital admission for pneumonia. Who present pcr = 66 mg/L and =150 mg/L at inclusion or Pandemic score [13] on admission > 200 with pcr 9.7-149 mg/L at inclusion. WHO scale level 4 [14], with need for oxygen therapy in NG = 1 lpm to maintain saturation = 94%. ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Anosmia. Anosmia;R43.0
2
Medical Condition: COVID - 19. COVID-19, virus identified;U07.1
2
Medical Condition: COVID 19;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: COVID-19
2
Medical Condition: COVID-19 (SARS-CoV-2 infection) Infections and Infestations
2
Medical Condition: COVID-19 (SARS-CoV-2 infection) related pneumonia Infections and Infestations
2
Medical Condition: COVID-19 Delta Variant; COVID-19 Delta Variant;Infection - Other infectious diseases;Respiratory - Other respiratory disorders / diseases;Emergency medicine - Other emergency care
2
Medical Condition: COVID-19 patients with persistent olfactory dysfunction Olfactory dysfunction, COVID-19, Olfactory training, Intranasal corticosteroids;Olfactory dysfunction, COVID-19, Olfactory training, Intranasal corticosteroids
2
Medical Condition: COVID-19;Type 2 diabetes;Steroid induced hyperglycaemia; COVID-19 Type 2 diabetes Steroid induced hyperglycaemia;Metabolic and Endocrine - Diabetes;Infection - Other infectious diseases;Respiratory - Other respiratory disorders / diseases
2
Medical Condition: COVID19. COVID-19, virus identified;U07.1
2
Medical Condition: COVID19;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Completed
2
Medical Condition: Coronavirus disease 2019 (COVID-19) COVID-19, pneumonia;C000657245
2
Medical Condition: Enfermedad en pacientes vulnerables con COVID-19 MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Health Condition 1: B338- Other specified viral diseases
2
Medical Condition: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
2
Medical Condition: Hospitalized patients with COVID-19 requiring respiratory support MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Hospitalized patients with Covid-19 pneumonia who do not require oxygen therapy on admission associated with at least two of the three following factors related with severe Covid-19: lactate dehydrogenase > 245 U/L, C-reactive protein > 100 mg/L and lymphocyte count < 800 cells/µL.;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Loss of smell after COVID-19 infection
2
Medical Condition: Loss of smell after COVID-19 infection, persisting after 4 weeks;Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
2
Medical Condition: Moderate Covid-19 pneumonia Moderate Covid 19, Moderate pneumonia, Covid 19 pneumonia, Methylprednisolone, Dexamethasone;Moderate Covid 19, Moderate pneumonia, Covid 19 pneumonia, Methylprednisolone, Dexamethasone
2
Medical Condition: Novel Coronavirus Pneumonia (COVID-19)
2
Medical Condition: Persistent (>1 month) loss of smell within 3 months of COVID-19 (SARS-CoV-2 infection) diagnosis based on a positive test Infections and Infestations
2
Medical Condition: Post Covid-19 Olfactory dysfunction
2
Medical Condition: SARS-CoV-2 infection (COVID-19) MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: The eligible COVID-19 patients who admit at Ramathibodi Hospitel, Ramathibodi Hospital and Ramathibodi Chakri Naruebodindra Hospital with new onset smell loss who capable to perform nasal irrigation themselves. COVID-19, Anosmia, Hyposmia, Budesonide;COVID-19, Anosmia, Hyposmia, Budesonide
2
Medical Condition: acute hypoxemic respiratory failure (AHRF);Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
mehr ...